Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity
JAMA · 2023
DOI: 10.1001/jama.2023.1002 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, 2023. Verfasst von Marc G Ghany und 1 weiteren Autor:innen. Beteiligte Einrichtung: Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. Hauptthemen laut MEDLINE: Acetaminophen, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
- Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.
Zitieren
APA
Ghany, M. G., & Watkins, P. B. (2023). Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity. JAMA. https://doi.org/10.1001/jama.2023.1002
Vancouver
Ghany MG, Watkins PB. Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity. JAMA. 2023. doi:10.1001/jama.2023.1002
BibTeX
@article{Ghany2023,
author = {Ghany, Marc G and Watkins, Paul B},
title = {Moving the Needle to Reduce Acetaminophen (Paracetamol) Hepatotoxicity},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.1002}
}
EUVIMED